{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T18:34:57Z","timestamp":1717526097705},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T00:00:00Z","timestamp":1303171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s12149-011-0490-2","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T02:11:23Z","timestamp":1303092683000},"page":"478-485","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of parameters of 123I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features"],"prefix":"10.1007","volume":"25","author":[{"given":"Yumiko","family":"Uchiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Momose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"key":"490_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06898.x","volume":"920","author":"IG McKeith","year":"2000","unstructured":"McKeith IG. Clinical Lewy body syndromes. Ann N Y Acad Sci. 2000;920:1\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"490_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51:745\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl","key":"490_CR3","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","volume":"32","author":"DB Calne","year":"1992","unstructured":"Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson\u2019s disease. Ann Neurol. 1992;32(Suppl):S125\u20137.","journal-title":"Ann Neurol"},{"key":"490_CR4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","volume":"57","author":"AJ Hughes","year":"2001","unstructured":"Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease. Neurology. 2001;57:1497\u20139.","journal-title":"Neurology"},{"key":"490_CR5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2008.02372.x","volume":"16","author":"H Sawada","year":"2009","unstructured":"Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R, et al. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol. 2009;16:174\u201382.","journal-title":"Eur J Neurol"},{"key":"490_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2005;76:249\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"490_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH, Excellence NIfC. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5:235\u201345.","journal-title":"Lancet Neurol"},{"key":"490_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"M Yoshita","year":"1998","unstructured":"Yoshita M. Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 1998;155:60\u20137.","journal-title":"J Neurol Sci"},{"key":"490_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","volume":"18","author":"J Taki","year":"2004","unstructured":"Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med. 2004;18:453\u201361.","journal-title":"Ann Nucl Med"},{"key":"490_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(00)00279-3","volume":"175","author":"A Druschky","year":"2000","unstructured":"Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson\u2019s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci. 2000;175:3\u201312.","journal-title":"J Neurol Sci"},{"key":"490_CR11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology. 1999;53:1020\u20135.","journal-title":"Neurology"},{"key":"490_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-1838(94)90023-X","volume":"49","author":"S Hakusui","year":"1994","unstructured":"Hakusui S, Yasuda T, Yanagi T, Tohyama J, Hasegawa Y, Koike Y, et al. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1994;49:81\u20134.","journal-title":"J Auton Nerv Syst"},{"key":"490_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"490_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s002590050544","volume":"27","author":"J Taki","year":"2000","unstructured":"Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. Eur J Nucl Med. 2000;27:566\u201373.","journal-title":"Eur J Nucl Med"},{"key":"490_CR15","first-page":"71","volume":"41","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71\u20137.","journal-title":"J Nucl Med"},{"key":"490_CR16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain. 2008;131:642\u201350.","journal-title":"Brain"},{"key":"490_CR17","first-page":"784","volume":"33","author":"H Takano","year":"1993","unstructured":"Takano H, Yoshimura N. Markedly decreased cardiac uptake with 123I-MIBG scintigraphy in a case of pure progressive autonomic failure. Rinsho Shinkeigaku. 1993;33:784\u20136.","journal-title":"Rinsho Shinkeigaku"},{"key":"490_CR18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.70.6.781","volume":"70","author":"H Watanabe","year":"2001","unstructured":"Watanabe H, Ieda T, Katayama T, Takeda A, Aiba I, Doyu M, et al. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2001;70:781\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"490_CR19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.71.5.583","volume":"71","author":"M Yoshita","year":"2001","unstructured":"Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer\u2019s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2001;71:583\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"490_CR20","first-page":"1099","volume":"47","author":"K Kashihara","year":"2006","unstructured":"Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson\u2019s disease and dementia with Lewy bodies. J Nucl Med. 2006;47:1099\u2013101.","journal-title":"J Nucl Med"},{"key":"490_CR21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","volume":"163","author":"S Gilman","year":"1999","unstructured":"Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94\u20138.","journal-title":"J Neurol Sci"},{"key":"490_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"490_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele\u2013Richardson\u2013Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology"},{"key":"490_CR24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"490_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02988527","volume":"17","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H, Momose M, Kanaya S, Kondo C, Kusakabe K, Mitsuhashi N. Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems. Ann Nucl Med. 2003;17:309\u201313.","journal-title":"Ann Nucl Med"},{"key":"490_CR26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00006231-199906000-00007","volume":"20","author":"M Momose","year":"1999","unstructured":"Momose M, Kobayashi H, Iguchi N, Matsuda N, Sakomura Y, Kasanuki H, et al. Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl Med Commun. 1999;20:529\u201335.","journal-title":"Nucl Med Commun"},{"key":"490_CR27","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/0735-1097(93)90786-Z","volume":"22","author":"DS Goldstein","year":"1993","unstructured":"Goldstein DS, Eisenhofer G, Dunn BB, Armando I, Lenders J, Grossman E, et al. Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol. 1993;22:1961\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"490_CR28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.10236","volume":"52","author":"ST Li","year":"2002","unstructured":"Li ST, Dendi R, Holmes C, Goldstein DS. Progressive loss of cardiac sympathetic innervation in Parkinson\u2019s disease. Ann Neurol. 2002;52:220\u20133.","journal-title":"Ann Neurol"},{"key":"490_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0969-8051(94)00084-W","volume":"22","author":"TR Degrado","year":"1995","unstructured":"Degrado TR, Zalutsky MR, Vaidyanathan G. Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol. 1995;22:1\u201312.","journal-title":"Nucl Med Biol"},{"key":"490_CR30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diabetes.45.6.801","volume":"45","author":"O Schnell","year":"1996","unstructured":"Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes. 1996;45:801\u20135.","journal-title":"Diabetes"},{"key":"490_CR31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1253\/circj.CJ-08-0614","volume":"73","author":"K Sakata","year":"2009","unstructured":"Sakata K, Iida K, Mochizuki N, Ito M, Nakaya Y. Physiological changes in human cardiac sympathetic innervation and activity assessed by (123)I-metaiodobenzylguanidine (MIGB) imaging. Circ J. 2009;73:310\u20135.","journal-title":"Circ J"},{"key":"490_CR32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12149-008-0156-x","volume":"22","author":"S Nagamachi","year":"2008","unstructured":"Nagamachi S, Wakamatsu H, Kiyohara S, Fujita S, Futami S, Tamura S, et al. Usefulness of rCBF analysis in diagnosing Parkinson\u2019s disease: supplemental role with MIBG myocardial scintigraphy. Ann Nucl Med. 2008;22:557\u201364.","journal-title":"Ann Nucl Med"},{"key":"490_CR33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19:630\u201340.","journal-title":"Mov Disord"},{"key":"490_CR34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.20384","volume":"20","author":"M Suzuki","year":"2005","unstructured":"Suzuki M, Hattori N, Orimo S, Fukumitsu N, Abo M, Kono Y, et al. Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report. Mov Disord. 2005;20:634\u20136.","journal-title":"Mov Disord"},{"key":"490_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mds.21701","volume":"23","author":"A Quattrone","year":"2008","unstructured":"Quattrone A, Bagnato A, Annesi G, Novellino F, Morgante L, Savettieri G, et al. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson\u2019s disease. Mov Disord. 2008;23:21\u20137.","journal-title":"Mov Disord"},{"key":"490_CR36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/mds.20594","volume":"20","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Yokochi M, Kojo T, Uchihara T, Takahashi A, et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord. 2005;20:1350\u20133.","journal-title":"Mov Disord"},{"key":"490_CR37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","volume":"74","author":"JC Klein","year":"2010","unstructured":"Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology. 2010;74:885\u201392.","journal-title":"Neurology"},{"key":"490_CR38","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1212\/01.wnl.0000277450.49788.82","volume":"69","author":"H Oka","year":"2007","unstructured":"Oka H, Yoshioka M, Morita M, Onouchi K, Suzuki M, Ito Y, et al. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology. 2007;69:1460\u20135.","journal-title":"Neurology"},{"key":"490_CR39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.67.5.620","volume":"67","author":"GK Wenning","year":"1999","unstructured":"Wenning GK, Scherfler C, Granata R, B\u00f6sch S, Verny M, Chaudhuri KR, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1999;67:620\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"490_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00259-009-1202-1","volume":"37","author":"K Ishibashi","year":"2010","unstructured":"Ishibashi K, Saito Y, Murayama S, Kanemaru K, Oda K, Ishiwata K, et al. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson\u2019s disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging. 2010;37:3\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"490_CR41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","volume":"50","author":"P Jokinen","year":"2009","unstructured":"Jokinen P, Helenius H, Rauhala E, Bruck A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med. 2009;50:893\u20139.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-011-0490-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-011-0490-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-011-0490-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:18Z","timestamp":1559450478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-011-0490-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1007\/s12149-011-0490-2","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,19]]}}}